[What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D010879:Piperazines; D010653:Phenylbutazone
Que peut-on attendre d'un anti-inflammatoire après 3 ans d'expérimentation et de pratique rhumatologique.